Drug Shortage Report for PMS-NIFEDIPINE ER
Report ID | 72632 |
Drug Identification Number | 02416301 |
Brand name | PMS-NIFEDIPINE ER |
Common or Proper name | NIFEDIPINE ER |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | NIFEDIPINE |
Strength(s) | 60MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C08CA |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2019-10-16 |
Estimated end date | 2021-09-07 |
Actual end date | 2021-10-14 |
Shortage status | Resolved |
Updated date | 2021-10-15 |
Company comments | Replaced pms-NIFEDIPINE ER 60mg T BLI 2X15 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-01-16 | English | Compare |